BIHi045-A-2

The cell line is not validated yet.

General

Cell Line

hPSCreg name BIHi045-A-2
Cite as:
BIHi045-A-2
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 21st February 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Berlin Institute of Health (BIH)

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Monocarboxylate transporter 8 deficiency
  • X-linked intellectual disability-hypotonia syndrome
  • MCT8 deficiency
  • AHDS
show more synonyms
Genetic variants
SLC16A2 (target)
Xq13.2
NM_006517.3:c.(1201G>A)
NM_006517.3(NP_006508.1):p.G401R
hemizygous

Ethics

Also have a look at the ethics information for the parental line BIHi045-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line BIHi045-A.

Reprogramming method

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line BIHi045-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • MCT8-Specific Thyroid Hormone Cell Membrane Transporter Deficiency
  • Monocarboxylate Transporter 8 Deficiency
  • Allan-Herndon-Dudley Syndrome
Genetic modifications
SLC16A2 (target)
Isogenic modification
Xq13.2